Shandong Shanda Wit Science and Technology Co Ltd (000915) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Shanda Wit Science and Technology Co Ltd (000915) has a cash flow conversion efficiency ratio of 0.152x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥620.45 Million ≈ $90.79 Million USD) by net assets (CN¥4.08 Billion ≈ $596.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shandong Shanda Wit Science and Technolo net asset quality index to measure how much of total assets are equity-financed.
Shandong Shanda Wit Science and Technology Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shandong Shanda Wit Science and Technolo (000915) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Shandong Shanda Wit Science and Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Shanda Wit Science and Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yatharth Hospital & Trauma Care Services Limited
NSE:YATHARTH
|
0.027x |
|
Nanjing Red Sun Co Ltd
SHE:000525
|
0.021x |
|
Shandong Jinjing Science and Technology Stock Co Ltd
SHG:600586
|
-0.032x |
|
Luzerner Kantonalbank AG
LSE:0QNU
|
0.004x |
|
Zhejiang Truelove Vogue Co Ltd
SHE:003041
|
0.010x |
|
Guan Chong Bhd
KLSE:5102
|
0.188x |
|
Morguard Corporation
TO:MRC
|
0.007x |
|
Arctech Solar Holding Co Ltd
SHG:688408
|
0.068x |
Annual Cash Flow Conversion Efficiency for Shandong Shanda Wit Science and Technology Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Shandong Shanda Wit Science and Technology Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see 000915 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.41 Billion ≈ $645.68 Million |
CN¥929.61 Million ≈ $136.03 Million |
0.211x | -19.35% |
| 2023-12-31 | CN¥4.50 Billion ≈ $658.00 Million |
CN¥1.17 Billion ≈ $171.89 Million |
0.261x | -11.32% |
| 2022-12-31 | CN¥4.06 Billion ≈ $594.32 Million |
CN¥1.20 Billion ≈ $175.07 Million |
0.295x | +32.48% |
| 2021-12-31 | CN¥3.40 Billion ≈ $497.44 Million |
CN¥755.85 Million ≈ $110.61 Million |
0.222x | -11.27% |
| 2020-12-31 | CN¥2.94 Billion ≈ $429.52 Million |
CN¥735.55 Million ≈ $107.63 Million |
0.251x | +164.15% |
| 2019-12-31 | CN¥2.57 Billion ≈ $375.65 Million |
CN¥243.54 Million ≈ $35.64 Million |
0.095x | -58.77% |
| 2018-12-31 | CN¥2.34 Billion ≈ $342.53 Million |
CN¥538.56 Million ≈ $78.81 Million |
0.230x | +19.80% |
| 2017-12-31 | CN¥2.22 Billion ≈ $324.66 Million |
CN¥426.11 Million ≈ $62.35 Million |
0.192x | -25.26% |
| 2016-12-31 | CN¥1.95 Billion ≈ $285.25 Million |
CN¥500.91 Million ≈ $73.30 Million |
0.257x | +48.70% |
| 2015-12-31 | CN¥1.68 Billion ≈ $245.77 Million |
CN¥290.24 Million ≈ $42.47 Million |
0.173x | -5.97% |
| 2014-12-31 | CN¥1.48 Billion ≈ $216.90 Million |
CN¥272.41 Million ≈ $39.86 Million |
0.184x | -1.32% |
| 2013-12-31 | CN¥1.16 Billion ≈ $169.76 Million |
CN¥216.05 Million ≈ $31.62 Million |
0.186x | +7.77% |
| 2012-12-31 | CN¥946.05 Million ≈ $138.44 Million |
CN¥163.48 Million ≈ $23.92 Million |
0.173x | -4.43% |
| 2011-12-31 | CN¥769.24 Million ≈ $112.56 Million |
CN¥139.09 Million ≈ $20.35 Million |
0.181x | -38.03% |
| 2010-12-31 | CN¥649.52 Million ≈ $95.05 Million |
CN¥189.51 Million ≈ $27.73 Million |
0.292x | +18.77% |
| 2009-12-31 | CN¥526.71 Million ≈ $77.07 Million |
CN¥129.39 Million ≈ $18.93 Million |
0.246x | +16.04% |
| 2008-12-31 | CN¥443.06 Million ≈ $64.83 Million |
CN¥93.80 Million ≈ $13.73 Million |
0.212x | -17.66% |
| 2007-12-31 | CN¥393.55 Million ≈ $57.59 Million |
CN¥101.20 Million ≈ $14.81 Million |
0.257x | +79.88% |
| 2006-12-31 | CN¥363.40 Million ≈ $53.18 Million |
CN¥51.95 Million ≈ $7.60 Million |
0.143x | -22.52% |
| 2005-12-31 | CN¥343.51 Million ≈ $50.27 Million |
CN¥63.38 Million ≈ $9.27 Million |
0.184x | +87.65% |
| 2004-12-31 | CN¥310.43 Million ≈ $45.43 Million |
CN¥30.52 Million ≈ $4.47 Million |
0.098x | +1111.11% |
| 2003-12-31 | CN¥299.64 Million ≈ $43.85 Million |
CN¥2.43 Million ≈ $355.95K |
0.008x | +112.45% |
| 2002-12-31 | CN¥253.39 Million ≈ $37.08 Million |
CN¥-16.53 Million ≈ $-2.42 Million |
-0.065x | -11925.11% |
| 2001-12-31 | CN¥245.49 Million ≈ $35.92 Million |
CN¥-133.16K ≈ $-19.49K |
-0.001x | +99.84% |
| 2000-12-31 | CN¥258.69 Million ≈ $37.85 Million |
CN¥-90.48 Million ≈ $-13.24 Million |
-0.350x | -303.55% |
| 1999-12-31 | CN¥262.99 Million ≈ $38.48 Million |
CN¥45.19 Million ≈ $6.61 Million |
0.172x | -12.93% |
| 1998-12-31 | CN¥122.61 Million ≈ $17.94 Million |
CN¥24.20 Million ≈ $3.54 Million |
0.197x | -- |
About Shandong Shanda Wit Science and Technology Co Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more